Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of Helicobacter pylori eradication therapy immediately after endoscopic submucosal dissection.
Takahashi Y, Takeuchi T, Kojima Y, Nagami Y, Ominami M, Uedo N, Hamada K, Suzuki H, Oda I, Miyaoka Y, Yamanouchi S, Tokioka S, Tomatsuri N, Yoshida N, Naito Y, Nonaka T, Kodashima S, Ogata S, Hongo Y, Oshima T, Li Z, Shibagaki K, Oikawa T, Tominaga K, Higuchi K. Takahashi Y, et al. J Gastroenterol Hepatol. 2018 Jul;33(7):1341-1346. doi: 10.1111/jgh.14073. Epub 2018 Mar 7. J Gastroenterol Hepatol. 2018. PMID: 29265496 Clinical Trial.
Vonoprazan, a Novel Potassium-Competitive Acid Blocker, Should Be Used for the Helicobacter pylori Eradication Therapy as First Choice: A Large Sample Study of Vonoprazan in Real World Compared with Our Randomized Control Trial Using Second-Generation Proton Pump Inhibitors for Helicobacter pylori Eradication Therapy.
Ozaki H, Harada S, Takeuchi T, Kawaguchi S, Takahashi Y, Kojima Y, Ota K, Hongo Y, Ashida K, Sakaguchi M, Tokioka S, Sakamoto H, Furuta T, Tominaga K, Higuchi K. Ozaki H, et al. Among authors: takahashi y. Digestion. 2018;97(3):212-218. doi: 10.1159/000485097. Epub 2018 Jan 31. Digestion. 2018. PMID: 29393194 Clinical Trial.
Determination of the adequate dosage of rebamipide, a gastric mucoprotective drug, to prevent low-dose aspirin-induced gastrointestinal mucosal injury.
Ota K, Takeuchi T, Nouda S, Ozaki H, Kawaguchi S, Takahashi Y, Harada S, Edogawa S, Kojima Y, Kuramoto T, Higuchi K. Ota K, et al. Among authors: takahashi y. J Clin Biochem Nutr. 2016 Nov;59(3):231-237. doi: 10.3164/jcbn.16-49. Epub 2016 Oct 7. J Clin Biochem Nutr. 2016. PMID: 27895392 Free PMC article.
Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor.
Takeuchi T, Takahashi Y, Kawaguchi S, Ota K, Harada S, Kojima Y, Sakamoto H, Kuramoto T, Kojima K, Sanomura M, Hoshimoto M, Higashino T, Itabashi T, Takada K, Sakaguchi M, Tominaga K, Kusano M, Higuchi K. Takeuchi T, et al. Among authors: takahashi y. J Gastroenterol Hepatol. 2018 Mar;33(3):623-630. doi: 10.1111/jgh.13970. J Gastroenterol Hepatol. 2018. PMID: 28865098 Clinical Trial.
Dual antiplatelet therapy does not affect the incidence of low-dose aspirin-induced small intestinal mucosal injury in patients after percutaneous coronary intervention for coronary stenosis: a multicenter cross-sectional study.
Hara A, Ota K, Takeuchi T, Kojima Y, Hirata Y, Ozaki H, Kawaguchi S, Takahashi Y, Harada S, Sakanaka T, Ogura T, Nouda S, Kakimoto K, Kawakami K, Asai A, Fukunishi S, Sanomura M, Tominaga K, Higuchi K. Hara A, et al. Among authors: takahashi y. J Clin Biochem Nutr. 2018 Nov;63(3):224-229. doi: 10.3164/jcbn.18-16. Epub 2018 May 25. J Clin Biochem Nutr. 2018. PMID: 30487673 Free PMC article.
Is a proton-pump inhibitor necessary after endoscopic submucosal dissection for superficial esophageal neoplasms? A propensity score analysis.
Kanaoka H, Iwatsubo T, Takeuchi T, Kojima Y, Takahashi Y, Hakoda A, Nishida S, Kawaguchi S, Ota K, Shiba M, Higuchi K. Kanaoka H, et al. Among authors: takahashi y. Therap Adv Gastroenterol. 2020 Nov 24;13:1756284820974908. doi: 10.1177/1756284820974908. eCollection 2020. Therap Adv Gastroenterol. 2020. PMID: 33281938 Free PMC article.
Risk factors for postoperative bleeding and early death in percutaneous endoscopic gastrostomy: A multicenter retrospective study.
Ota K, Takeuchi T, Masuda D, Sanomura M, Kojima K, Nakanishi Y, Hoshimoto M, Higashino T, Imoto A, Okada T, Nouda S, Miyazaki H, Ozaki H, Fukuda KH, Kuramoto T, Sugawara N, Onishi T, Takahashi Y, Tsujimoto H, Yokoya Y, Kawabata K, Nishida S, Hakoda A, Iwatsubo T, Kawaguchi S, Kojima Y, Higuchi K. Ota K, et al. Among authors: takahashi y. J Gastroenterol Hepatol. 2022 Jan;37(1):97-103. doi: 10.1111/jgh.15680. Epub 2021 Sep 13. J Gastroenterol Hepatol. 2022. PMID: 34478183
12,142 results
You have reached the last available page of results. Please see the User Guide for more information.